Fox Run Management’s Ocular Therapeutix OCUL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-25,597	Closed	-$106K	–	810
2022 Q3	$106K	Buy	+25,597	New	+$106K	0.04%	545
2022 Q1	–	Sell	-12,752	Closed	-$89K	–	644
2021 Q4	$89K	Buy	+12,752	New	+$89K	0.05%	426